Sasankan, S., Rebuck, L., Darrah, G., Harari Turquie, M., & Rabinowitz, I. (2020). Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy. Case Reports in Oncology, 13(3), 1239. https://doi.org/10.1159/000510096
Chicago Style (17th ed.) CitationSasankan, Shenthol, Lorraine Rebuck, Gloria Darrah, Moises Harari Turquie, and Ian Rabinowitz. "Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy." Case Reports in Oncology 13, no. 3 (2020): 1239. https://doi.org/10.1159/000510096.
MLA (9th ed.) CitationSasankan, Shenthol, et al. "Metastatic Pancreatic Cancer with BRAF and P53 Mutations: Case Report of Therapeutic Response to Doublet Targeted Therapy." Case Reports in Oncology, vol. 13, no. 3, 2020, p. 1239, https://doi.org/10.1159/000510096.